|
Volumn 26, Issue 1, 2016, Pages 15-20
|
Discovery of the imidazole-derived GPR40 agonist AM-3189
a a a a a a a a a a a a a a a a a a |
Author keywords
Agonist; AM 3189; AMG 837; FFAR1; GPCR; GPR40; Insulin secretagogue; Type II diabetes
|
Indexed keywords
AM 3189;
ANTIDIABETIC AGENT;
G PROTEIN COUPLED RECEPTOR 40;
GLUCOSE;
UNCLASSIFIED DRUG;
AM-3189;
FFAR1 PROTEIN, HUMAN;
G PROTEIN COUPLED RECEPTOR;
IMIDAZOLE;
IMIDAZOLE DERIVATIVE;
ARTICLE;
CHO CELL LINE;
DRUG EFFICACY;
ENANTIOMER;
FOLLOW UP;
GLUCOSE BLOOD LEVEL;
IN VIVO STUDY;
INSULIN RELEASE;
LIGAND BINDING;
NON INSULIN DEPENDENT DIABETES MELLITUS;
RACEMIC MIXTURE;
STRUCTURE ACTIVITY RELATION;
SUZUKI REACTION;
AGONISTS;
ANIMAL;
CHEMICAL STRUCTURE;
CHEMISTRY;
DOG;
DOSE RESPONSE;
DRUG DEVELOPMENT;
HUMAN;
MACACA FASCICULARIS;
MOUSE;
RAT;
SYNTHESIS;
ANIMALS;
DOGS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG DISCOVERY;
HUMANS;
IMIDAZOLES;
MACACA FASCICULARIS;
MICE;
MOLECULAR STRUCTURE;
RATS;
RECEPTORS, G-PROTEIN-COUPLED;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 84949604818
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2015.11.050 Document Type: Article |
Times cited : (17)
|
References (22)
|